This regulation is affected by APOE polymorphism, and APOE ɛ4 polymorphism is known to increase the risk of atherosclerosis and neurodegenerative disorders, including Alzheimer’s disease and dementia. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.